Key result
Higher prolactin in PCOS is linked to increased RDW-SD and lower Hb, but not CRP.
Why the study?
The study aimed to investigate the relationship between prolactin levels and inflammatory markers in women with polycystic ovary syndrome compared to controls.
Are prolactin levels associated with inflammatory markers in women with polycystic ovary syndrome?
Observational (n=120)
Are prolactin levels associated with inflammatory markers in women with polycystic ovary syndrome?
Answers are grounded in this paper and cite their sources.
Higher prolactin levels may be associated with increased inflammation and altered hematological parameters in women with PCOS.
Aims: This study aimed to investigate the relationship between prolactin (PRL) levels and inflammatory markers in women with polycystic ovary syndrome (PCOS) compared to controls.. Methods: A total of 120 women, 60 with PCOS and 60 controls, were included in this study. The participants were divided into four groups based on their PRL levels: hyperprolactinemia PCOS, normal PRL PCOS, hyperprolactinemia controls, and normal PRL controls. The levels of various inflammatory markers, including C-reactive protein (CRP), Hb, red cell distribution width (RDW-SD), mean platelet volume (MPV), and platelet distribution width (PDW), were measured and compared between the groups. The correlation between PRL levels and inflammatory markers was also analyzed. Results: The results show that the mean value of CRP was higher in the PCOS group with hyperprolactinemia (2.15±1.61) compared to the PCOS group with normal PRL levels (1.68±1.19), but the difference was not statistically significant (p=0.432). The correlation results show that there was a statistically significant negative correlation between PRL levels and Hb (r=-0.313, p=0.015) and a positive correlation between PRL levels and RDW-SD (r=0.352, p=0.006) in PCOS patients. In PCOS patients, higher PRL levels were associated with increased RDW-SD, decreased Hb levels, decreased platelet count, and increased MPV and PDW. However, there was no significant correlation between PRL levels and inflammatory markers in the control group. Conclusion: The results of this study suggest that higher PRL levels may be associated with increased inflammation in PCOS patients. However, further research is needed to understand the underlying mechanisms and potential clinical implications of these associations.
No takes yet. Share an insight, caveat, or question.
ÖNAL et al. (2023) conducted an observational in Polycystic ovary syndrome (n=120). Hyperprolactinemia vs. Normal prolactin levels was evaluated on C-reactive protein (CRP) levels (p=0.432). Higher prolactin levels in PCOS patients were associated with increased RDW-SD and decreased Hb, though CRP differences were not significant.
Synapse has enriched 10 related papers. Consider them for comparative context: